NEW YORK (Reuters Health) – The tyrosine-kinase inhibitor pazopanib seems to be a promising option for treating progressive metastatic differentiated thyroid cancer that is unresponsive to radioiodine therapy,…
NEW YORK (Reuters Health) – Rates of deep vein thrombosis (DVT) in immobilized stroke patients are lower when thigh-length graduated compression stockings are used rather than below-knee stockings,…
NEW YORK (Reuters Health) – Response rates are higher when bortezomib plus dexamethasone rather than vincristine plus doxorubicin plus dexamethasone (VAD) is used as induction therapy before stem-cell…
NEW YORK (Reuters Health) – Using the rapid-acting insulin analog glulisine instead of regular human insulin at mealtimes improves glycemic control in hospitalized patients with type 2 diabetes,…
NEW YORK (Reuters Health) – The concern about proton pump inhibitors (PPIs) possibly interfering with the efficacy of clopidogrel may be misdirected, according to a new report. It…
NEW YORK (Reuters Health) – Left atrial volume rather than diameter is more strongly associated with thromboembolic risk markers in patients with mitral stenosis, and should be used…
NEW YORK (Reuters Health) – Treating common warts with topical salicylic acid is less effective than cryotherapy with liquid nitrogen, a Dutch study has shown. Plantar warts, however,…
NEW YORK (Reuters Health) – A finding of homozygosity for mutations that cause Gaucher disease in patients who report no symptoms of the disorder warrants further followup. Manifestations…
NEW YORK (Reuters Health) – The risk of developing post-pericardiotomy syndrome (PPS) in cardiac surgery patients can be halved by treatment with colchicine, an international team has shown.…
NEW YORK (Reuters Health) – Compared with dual therapy for HIV, highly active antiretroviral therapy (HAART) in pregnant women is associated with an increased risk of preterm delivery,…
